The global diagnostics supplier said the multi-phase expansion aims to deliver more than 60 commercially available recombinant antigen products by 2030
According to the analysis, just 23% of patients aged 18–29 were formally diagnosed with TD
Highlighting KEYTRUDA & expanding cancer pipeline
The test is designed to help clinicians either rule in or rule out amyloid pathology in patients showing signs of cognitive decline
In the new study, scientists at the University of Virginia used gene-editing techniques to modify GLP-1 receptors in mice to make them more humanlike
Study published BY IIT Kanpur researchers could advance drug delivery and biomedical technologies
IIT Kanpur team has developed computational framework to map how cell signals influence gene activity across tissues
The move targets long-standing bottlenecks in MSC science, including cell-to-cell variability, immunocompatibility concerns, and inefficient manufacturing workflows
The 4,000-square-foot facility is designed as a hands-on hub where customers can work directly with scientists and engineers
The partnership integrates BD’s ZebraSci, a device-agnostic testing platform, with Suttons Creek’s expertise in combination product development and systems integration
SPARC enters definitive agreement to monetise rare paediatric disease PRV, unlocking capital for R&D and strategic growth
EUDRAGIT polymers remain a cornerstone technology in oral drug delivery
Collaboration integrates SmartChip PCR technology with cloud-based analytics to enable faster, standardised monitoring of antimicrobial resistance
Sanplatec is leading the industry in the field of containers and devices for cell culture and live transport
The collaboration underscores a broader industry shift toward hybrid research models that integrate computational biology with advanced experimental systems
These findings help explain how relapse-triggering memories can persist alongside those that support recovery
While many cases are treatable, a subset can become highly aggressive, spreading to distant organs and resisting conventional therapies
Pharma giant targets new standards of care
Subscribe To Our Newsletter & Stay Updated
